3W2S
EGFR kinase domain with compound4
Summary for 3W2S
Entry DOI | 10.2210/pdb3w2s/pdb |
Related | 3POZ 3W2O 3W2P 3W2Q 3W2R |
Descriptor | Epidermal growth factor receptor, 1-{3-[2-chloro-4-({5-[2-(2-hydroxyethoxy)ethyl]-5H-pyrrolo[3,2-d]pyrimidin-4-yl}amino)phenoxy]phenyl}-3-cyclohexylurea, SULFATE ION, ... (4 entities in total) |
Functional Keywords | anti-oncogene, cell cycle, disease mutation, kinase domain, receptor, transferase, transferase-transferase inhibitor complex, transferase/transferase inhibitor |
Biological source | Homo sapiens (human) |
Total number of polymer chains | 1 |
Total formula weight | 38320.65 |
Authors | Sogabe, S.,Kawakita, Y.,Igaki, S. (deposition date: 2012-12-03, release date: 2013-01-16, Last modification date: 2023-11-08) |
Primary citation | Sogabe, S.,Kawakita, Y.,Igaki, S.,Iwata, H.,Miki, H.,Cary, D.R.,Takagi, T.,Takagi, S.,Ohta, Y.,Ishikawa, T. Structure-Based Approach for the Discovery of Pyrrolo[3,2-d]pyrimidine-Based EGFR T790M/L858R Mutant Inhibitors. Acs Med.Chem.Lett., 4:201-205, 2013 Cited by PubMed: 24900643DOI: 10.1021/ml300327z PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (1.9 Å) |
Structure validation
Download full validation report